Abstract:Montserrat Masip, 1, 2, &ast Neus Pagès-Puigdemont, 1, 2, &ast Anna López-Ferrer, 2, 3, &ast Héctor David de Paz, 4, &ast Esther Serra-Baldrich, 2, 3, &ast Lluís Puig, 2, 3, &ast Pau Riera 1, 2, &ast 1 Pharmacy Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 2 Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain; 3 Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 4 Outcomes' 10 (a ProductLife Group Company), Castellón de la Plana, Spain &astThese authors contributed equally to this work Correspondence: Neus Pagès-Puigdemont, Pharmacy Service, Hospital de la Santa Creu i Sant Pau, Sant Quintí 81, Barcelona, 08041, Spain, Email Purpose: This study aims to map the clinical pathway for psoriasis and atopic dermatitis (AD) in a tertiary hospital to better understand patient needs and experiences, thereby suggesting improvements in patient-centered care. Methods: A mixed-method approach was utilised involving a literature review, a questionnaire for healthcare professionals (HCPs), and two focus groups (one with HCPs and the other with patients with psoriasis or AD). Ethical approvals were obtained, and informed consent was acquired from all participants. Results: Patients and HCPs identified significant delays in the pre-diagnosis phase, extending up to five years for psoriasis and three years for AD, adversely affecting the timely initiation of effective treatment. In addition, there were reported difficulties in obtaining appointments during flares, a lack of dermatologic emergencies, a need to increase human resources and physical space, and a need for telematic consultations for urgent cases. Discrepancies between HCPs' perceptions and patients' experiences highlighted unmet needs, particularly in primary care settings and emergency departments. Several strengths were also identified, including satisfactory experience in dermatology, the hospital's high level of specialisation in the management of complex patients, optimal communication between services, consideration of patient preferences, and proper advice on hospital pharmacy care and administration support of treatment and adherence monitoring. Conclusion: The findings underscore the necessity for interventions to reduce wait times and improve treatment immediacy and effectiveness post-diagnosis. The insights from this study can direct enhancements in patient management and satisfaction for individuals with psoriasis and AD. Plain Language Summary: This study looked into how patients with psoriasis and atopic dermatitis (AD) are treated in a tertiary hospital. It focused on understanding the time it takes for patients to receive help and their satisfaction with the care received. By talking to doctors and patients, the researchers learned about the challenges in the early stages of these diseases and the delays in starting treatment or in the treatment process, among others. They discovered that these patients often wait too long before seeing a dermatologist, leading to a delay in treatment access. The study suggests that quicker diagnosis and treatment could improve how these conditions are managed and increase patient satisfaction. Keywords: psoriasis, atopic dermatitis, care pathway, patient centered care Psoriasis and atopic dermatitis (AD) are common inflammatory skin diseases. Despite sharing some features, such as infiltration of immune cells and altered expression of proinflammatory cytokines, 1 they are different clinical conditions. 2,3 Psoriasis, with an estimated global prevalence of 1–3%, in its most common form, plaque psoriasis, is characterised by erythematous, well-demarcated plaques with coarse scale 3,4 On the other hand, AD is a chronic, pruritic and inflammatory skin disease, which most commonly affects children (20%), but also affects adults (2,5%). 5 Both conditions can also occur with flares and are associated with other comorbidities. 6,7 Psoriasis is related to psoriatic arthritis, cardiovascular disease, malignancies, diabetes, hypertension, metabolic syndrome, inflammatory bowel disease, infections, and autoimmune disorders. 8 Furthermore, AD is associated with allergic rhinitis, asthma and food allergy. 9 Consequently, both psoriasis and AD, in addition to their associated comorbidities, can negatively impact patients' quality of life (QoL) and psychological wellbeing. 9,10 The current therapeutic strat -Abstract Truncated-

Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care

The atopic dermatitis patient journey: insights from a qualitative study

Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan

Patients' and caregivers' perspectives of the atopic dermatitis journey

Quality of Care and Management of Atopic Dermatitis Across Different Levels of Healthcare-A Survey-Based Patient Experience

Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches

Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care

405 Understanding patient experience and factors influencing patient preference in the treatment of moderate-to-severe atopic dermatitis through in-depth qualitative patient interviews

The development and initial evaluation of conversation cards for optimizing consultations for patients with atopic dermatitis

Qualitative study with mothers of children with atopic dermatitis: emotional and social impacts

Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice

The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs

The burden of atopic dermatitis in Australia: Medical care, treatment satisfaction, financial impact, long‐term control and quality of life

Addressing Unmet Needs in Atopic Dermatitis: Evaluating Disease-Modifying Capabilities of Current and Emerging Therapies

An Expansive Review

A Mobile Health App for Facilitating Disease Management in Children With Atopic Dermatitis: Feasibility and Impact Study

Patient Burden of Atopic Dermatitis and Opportunities for Real-World Self-Monitoring

A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative

Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review

710 - Improving pediatric atopic dermatitis care: online intervention in the Deep South

Defining the Care Pathway in Patients with Psoriasis and Atopic Dermatitis